Increase of the lipoprotein-lipase activity in human skeletal muscle during clof ibrate administration (Q28325590)

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

26 April 2023

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

26 April 2023

author name string

H. Lithell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A417937

29 June 2022

J. Boberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A417937

29 June 2022

K. Hellsing

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A417937

29 June 2022

G. Lundqvist

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A417937

29 June 2022

B. Vessby

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A417937

full work available at URL

29 June 2022

language of work or name

English

0 references

publication date

April 1978

0 references

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2362.1978.tb00814.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2362.1978.tb00814.x/fullpdf

26 April 2023

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

European Journal of Clinical Investigation

26 April 2023

published in

0 references

volume

8

0 references

issue

2

0 references

page(s)

67-74

0 references

cites work

Glucagon secretion in primary endogenous hypertriglyceridemia before and after clofibrate treatment

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Lipoprotein lipase activity in human adipose tissue: assay methods. Relations to the serum triglyceride level in a normolipidemic population. The effect of ethyl chlorophenoxy isobutyrate

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1978.TB00814.X

Determination of lipoprotein-lipase activity in human skeletal muscle tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1978.TB00814.X

Quantitative and qualitative serum lipoprotein analysis. Part 1. Studies in healthy men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1978.TB00814.X

Tissue lipoprotein lipase in normal individuals and in individuals with exogenous hypertriglyceridemia and the relationship of this enzyme to assimilation of fat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1978.TB00814.X

The Current Status of Hypolipidemic Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1978.TB00814.X

Effects of clofibrate on glucose tolerance, serum insulin, serum lipoproteins and plasma fibrinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1978.TB00814.X

Treatment of hyperlipidemia

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man

26 April 2023

3

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia

26 April 2023

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Effect of clofibrate on postheparin plasma triglyceride lipase activities in patients with hypertriglyceridemia

26 April 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Quantitative determination of heparin released lipoprotein lipase activity in human plasma

26 April 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

SERIAL STUDIES ON THE METABOLISM OF HUMAN ADIPOSE TISSUE. I. LIPOGENESIS AND FREE FATTY ACID UPTAKE AND RELEASE IN SMALL ASPIRATED SAMPLES OF SUBCUTANEOUS FAT.

26 April 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

A method of determining lipoprotein-lipase activity in human adipose tissue

26 April 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

26 April 2023

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

[On a rapid determination of the cholesterol bound to the serum alpha- and beta-lipoproteins]

26 April 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Detection and characterization of hyperlipoproteinaemia in middle-aged men.

26 April 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

A Methodological Study of an Intravenous Fat Tolerance Test with IntralipidREmulsion

26 April 2023

23

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Mercury-Induced Renal Vascular Shut-Down: Observations in Experimental Acute Renal Failure

26 April 2023

25

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Mechanism of the hypolipemic effect of clofibrate in postabsorptive man

26 April 2023

26

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Effect of chlorophenoxyisobutyrate on the metabolism of endogenous glycerides in man

26 April 2023

28

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Effect of a hypolipidaemic drug (CH 13,437) on plasma and tissue lipids, and on the intravenous fat tolerance in man

26 April 2023

29

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Lipoprotein lipase: evidence for high- and low-affinity enzyme sites

26 April 2023

30

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Lipoprotein lipase activity in human adipose tissue I. Conditions for release and relationship to triglycerides in serum

26 April 2023

31

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Lipoprotein lipase activity of huuman adipose tissue in different types of hyperlipidemia

26 April 2023

32

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Effect of Fat Cell Size, Restrictive Diet and Diabetes on Lipoprotein Lipase Release by Human Adipose Tissue

26 April 2023

34

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Determinants of human adipose tissue lipoprotein lipase. Effect of diabetes and obesity on basal- and diet-induced activity

26 April 2023

35

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Lipoprotein-lipase activity in subcutaneous, adipose tissue in healthy subjects: variation of activity in a population of 60-year-old men.

26 April 2023

36

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

DETERMINATION OF HEPARIN-INDUCED LIPOPROTEIN LIPASE ACTIVITY IN HUMAN PLASMA

26 April 2023

39

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Regulation of adipose tissue lipoprotein lipase synthesis by intracellular free fatty acid

26 April 2023

43

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Inhibition of hormone-stimulated lipolysis by clofibrate. A possible mechanism for its hypolipidemic action

26 April 2023

44

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Inhibition of human fat cell adenylate cyclase by clofibrate

26 April 2023

45

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Lipolytic activity in rat heart

26 April 2023

47

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus

26 April 2023

48

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Effect of clofibrate on arginine-stimulated glucagon and insulin secretion in man

26 April 2023

51

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Effect of clofibrate on plasma glucose and serum immunoreactive insulin in patients with hyperlipoproteinemia.

26 April 2023

52

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Effects of clofibrate treatment on arginine-induced insulin secretion in endogenous hypertriglyceridemia

26 April 2023

53

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Glucagon physiology and pathophysiology

26 April 2023

56

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

Effect of glucagon: insulin ratios on hepatic metabolism

26 April 2023

57

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

The role of glucagon in the regulation of myocardial lipoprotein lipase activity

26 April 2023

58

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1978.TB00814.X

26 April 2023

Identifiers

0 references